Your Yourlocation: Home > Compared the use of tiotropium bromide(136310-93-5) and salmeterol in the treatment of COPD economic

At present, there are already cost-effectiveness studies on COPD, and almost all of the developed countries have taken samples of COPD to evaluate drug economics in developed areas. In fact, more environmental problems are exposed to developing countries, including China, but the study of drug economics for COPD in developing countries as a sample is currently a study of the gaps. Guidance to LABA or LAMA two programs for the treatment of moderate to severe COPD priority program, but did not indicate which program is the best choice. Therefore, from the perspective of Chinese patients, compared the use of salmeterol and tiotropium bromide(136310-93-5) in the treatment of COPD economic and effectiveness of its economic evaluation of pharmacology is valuable. It aims to provide scientific decision-making information for medical workers, health insurance departments and patients to choose COPD medications.

As a special dosage form, the inhaled drug can exert a systemic effect by allowing it to enter the body cycle directly through the inhalation, so that its efficacy and safety are higher than those of the oral drug. At the same time, inhaled drugs are mainly used for chronic obstructive pulmonary disease (COPD), asthma and other diseases of respiratory symptoms control, such as wheezing, dyspnea, respiratory distress, drug efficacy and safety can be the life of the crisis. At present, the evaluation criteria of inhaled drug generic drugs have been updated at home and abroad. The reason, mainly in the following three aspects:

1. Powder inhalant particle size, target site sedimentation rate and non-target site sedimentation rate and other pharmacological characteristics of the inconsistency, can cause adverse reactions increased or decreased efficacy;

2. The patient's inhalation of the treatment of a direct impact on drug compliance, inconsistent treatment can lead to treatment of patients discontinued.

3. The patent preparation of pharmaceutical products and inhalation device patent for a long time in the main drug, so the device can not be completely imitation device.

Address:211#Zhengfeng Building,Huanbaokejiyuan, Gaoxinkaifaqu, Jinan,250100,China TEL:086-531-82375818 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved